Actively Recruiting
Health Literacy-Based Nurse-Led Telehealth Support for Gout Self-Management: the Danish Randomized GOUTCONNECT Trial
Led by University of Aarhus · Updated on 2025-09-18
200
Participants Needed
5
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Aarhus
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating whether nurse-led telehealth support can help adults with gout better manage their condition and stick to their urate-lowering medication after leaving a rheumatology clinic. The study focuses on patients who have reached target serum urate levels and aims to support ongoing management over a 52-week period. Participants will be adults diagnosed with gout who are taking medications like allopurinol or Adenuric and can read and write Danish. Participants are randomly assigned to one of two groups: the intervention group receives nurse-led telehealth support with four options to choose from, including app-based information and reminders, letter reminders, SMS reminders every three months, or phone calls from nurses three times a year. The control group receives usual care, continuing follow-up with their general practitioner after hospital discharge, with information and recommendations sent to both the GP and the patient. During the study, participants will be monitored for maintaining healthy uric acid levels and the impact of gout on their lives after 52 weeks. Researchers will assess medication adherence and quality of life using questionnaires. The study includes ongoing support and follow-up to help participants manage their gout effectively, with all outcomes tracked over the course of one year.
CONDITIONS
Brief Title
Nurse-Led Telehealth for Gout
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Diagnosed with gout according to ACR/EULAR 2015 criteria
- Estimated Glomerular Filtration Rate (e-GFR) greater than 30 ml/min
- Prescribed allopurinol or Adenuric and achieved two consecutive serum urate levels below 0.36 mmol/L (or below 0.30 mmol/L for patients with tophi)
- Able to read and write Danish well enough to understand information and complete questionnaires
You will not qualify if you...
- Cognitively impaired and unable to understand or give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 52 weeks
Participants choose from four support options including app-based monitoring, quarterly reminders by letter or SMS, or phone call check-ins by a nurse to support gout self-management.
Quarterly contacts via app, letter, SMS, or phone calls depending on participant choice
Duration - 52 weeks
Participants in the control group continue with routine care by their general practitioner including annual monitoring and treatment according to discharge recommendations.
Annual visit with general practitioner
Trial Site Locations
Total: 5 locations
1
Aarhus University Hospital
Aarhus, Denmark, 8200
Actively Recruiting
2
Gødstrup Hospital
Herning, Denmark, 7400
Actively Recruiting
3
Horsens Hospital
Horsens, Denmark, 8700
Actively Recruiting
4
Randers Hospital
Randers, Denmark, 8930
Actively Recruiting
5
Silkeborg Hospital
Silkeborg, Denmark, 8600
Actively Recruiting
Research Team
A
Annette de Thurah, CNS, MPH, PHD
S
Sofie B Vestergaard, RN, MSc, PhD-fellow
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here